Summary
EQUITYBITES-(C)2011 M2 COMMUNICATIONS
Pharmaceutical company Orexo AB (STO:ORX.st) announced today that its partner ProStrakan Group plc (LSE:PSK.l), a specialty pharmaceutical company, has received approval from the US Food and Drug Administration (FDA) for Abstral.See the full content of this document
Extract
-Prostrakan Receives Fda Approval for Abstral in Us
Abstral is licensed for the treatment of breakth...
See the full content of this document
Sponsored links
